# Jiangyin USUN Biochemical Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/jiangyin-usun-biochemical-technology-co

- Industry: Biotechnology
- Headquarters: Jiangyin, China
- Website: www.usunbio.com
- Latest round: Series B (Feb 13, 2015)
- Investors on record: 3

## About

Founded in 2011 and based in Wuxi, China, Jiangyin USUN Biochemical Technology Co., Ltd. operates as a biotechnology company that focuses on the production of mussel mucin producer and related products. It was recognized as the National High-tech Enterprise. Bengt Samuelsson, one of the team members of the company, acquired the 1982 Nobel Prize in Medicine or Physiology. The company applied for 6 international invention patents. In February 2015, Jiangyin USUN Biochemical Technology Co., Ltd. closed a series B funding from returning investors China Venture Capital, Silan Venture Capital, and Yinxinggu Capital. In October 2025, Jiangyin USUN Biochemical Technology Co., Ltd. raised an undisclosed amount of venture funding led by new investor HighLight Capital, following by new investor Lu Hua Dao Sheng Capital.

The company mainly engaged in the research, development, production, and sales of mussel mucin as well as small molecule anti-inflammatory drugs. Its main product includes Functional Protein Active Dressing, Mucin Anal Dressing, Mucin Oral Gel, Mucin Nasal Spray, etc. The company also develops novel small molecule anti-inflammatory drugs for topical delivery, including respiratory and gastrointestinal system diseases, as well as drugs for ulcerative colitis and radiation enteritis.

The company generates revenue by providing mussel mucin as well as small-molecule anti-inflammatory drugs.

The company will use the latest funding for the clinical development of intradermal injection products for Class III medical devices using original biomedical material mussel adhesive protein, as well as chronic wound care products.

## Funding rounds

- Series B, Feb 13, 2015 — China Venture Capital, Yinxinggu Capital, Silan Venture Capital

## Investors

- China Venture Capital (https://capitalatlas.ai/funds/china-venture-capital) — Series B
- Yinxinggu Capital (https://capitalatlas.ai/funds/yinxinggu-capital) — Series B
- Silan Venture Capital — Series B